Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 2 2015

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

08 Genzyme
By Gil Roth
Published July 14, 2011
#8: Genzyme Corp. Headcount                     10,100 Year Established           1981 Pharma Revenues         $3,417  &nbs… Read More »
07 CSL
By Gil Roth
Published July 14, 2011
#7: CSL Headcount                  10,000 Year Established           1916 Pharma Revenues      $3,930           &… Read More »
06 Biogen
By Gil Roth
Published July 14, 2011
#6: Biogen Idec Headcount                   4,850 Year Established         2003 Pharma Revenues       $4,547           &n… Read More »
05 Baxter Bioscience
By Kristin Brooks
Published July 14, 2011
#5: Baxter Bioscience Headcount                      48,000 Year Established           1931 Pharma Revenues         $5,640 &nb… Read More »
04 Merck Serono
By Gil Roth
Published July 14, 2011
#4: Merck Serono Headcount                     40,562 Year Established           1668 Pharma Revenues         $7,641    &nb… Read More »
03 Novo Nordisk
By Gil Roth
Published July 14, 2011
#3: Novo Nordisk   Headcount                     29,423 Year Established           1989 Pharma Revenues         $10,835  &nbs… Read More »
02 Amgen
By Gil Roth
Published July 14, 2011
#2: Amgen, Inc.   Headcount                    17,000 Year Established          1980 Pharma Revenues        $14,660     … Read More »
01 F. Hoffman-La Roche
By Gil Roth
Published July 14, 2011
#1: F. Hoffman-La Roche   Headcount                   80,653 Year Established        1896 Pharma Revenues     $35,629       &… Read More »
10 Bristol-Myers Squibb
By Gil Roth
Published July 14, 2011
#10: Bristol-Myers Squibb   Headcount                  27,000 Year Established       1887 Pharma Revenues     $19,484       4% T… Read More »
02 Novartis
By Gil Roth
Published July 14, 2011
#2: Novartis   Headcount                         119,418 Year Established              1996 Pharma Revenues      &n… Read More »
01 Pfizer
By Gil Roth
Published July 14, 2011
#1: Pfizer Headcount                         110,600 Year Established              2000 Pharma Revenues         … Read More »
The Top 50 Biopharma Products
By Ronald A. Rader
Published July 14, 2011
A list of the best-selling biopharma products from 2010 Read More »
The Top 10 Biopharmaceutical Companies
By Gil Y. Roth
Published July 14, 2011
Our annual look at the 10 biggest biopharmaceutical players Read More »
By Kristin Brooks
Published July 13, 2011
News and video from the 47th annual DIA Meeting Read More »
Published July 13, 2011
Aslan Pharmaceuticals and Array BioPharma have entered into a license agreement to develop Array’s HER2/EGFR inhibitor, ARRY-543, currently in Phase II development for solid tumors. Read More »
By Steve Snyder
Published July 13, 2011
Excerpts from some favorite past articles Read More »
By Gil Roth
Published July 13, 2011
Plus: Strategic alliances, photo-essays, black swans and polio Read More »
Published July 7, 2011
Sigma-Aldrich unit launches ZFN-modified CHO cell lines for use in biopharma production. Read More »
By Gil Roth
Published June 29, 2011
Smyth named SVP, Clinical Development Read More »
By Gil Roth
Published June 22, 2011
Mitsubishi to gain 20% equity in new bio-CMO network, add global sales and marketing Read More »
By Tracy Cooley
Published June 22, 2011
Industry trends create opportunities for bio-CMOs and CROs Read More »
By Gil Roth
Published June 22, 2011
Cancels NDA and MAA and withdraws MS treatment from approved markets Read More »
Published June 14, 2011
Array BioPharma will restructure in an effort to extend its financial resources to focus on the development of key clinical programs: ARRY-520, a KSP inhibitor for multiple myeloma, ARRY-614, a p38 / Tie-2 inhibitor for myelodysplastic syndrome, and MEK162, a MEK inhibitor for cancer in co-development with Novartis. Read More »
By Gil Y. Roth
Published June 6, 2011
Managing preclinical operations Read More »
By William Downey, HighTech Business Decisions
Published June 6, 2011
Breaking down the Fujifilm Diosynth Biotechnologies deal Read More »
By Steve Snyder, Contributing Editor
Published June 6, 2011
A look at the effectiveness of employee training Read More »
Interview: Oskar Gold
By Gil Y. Roth, Contractu2008Pharma
Published June 6, 2011
Talking CRM, KAM, KPI and more with Vetter Read More »
Clusters’ Last Stand?
By Andrew MacGarvey, Quanticate
Published June 6, 2011
Does R&D benefit from bio-clusters? Read More »
CROs & Advanced Analytics
By Ralph Marcello and Raj Jayashankar, Deloitte Consulting
Published June 6, 2011
Accelerating R&D through data mining and bioanalytics Read More »
Advances in Drug Delivery
By Kristin Brooks, Contract Pharma
Published June 6, 2011
Expansion of biologics drives technology Read More »
Single-Use Trends
By Gil Roth, Contract Pharma
Published June 6, 2011
Technologies, regional growth drive market Read More »
Biopharma CMO Pricing Trends
By William Downey, MBA
Published June 6, 2011
A new report details the costs of bio-manufacturing Read More »
Biopharmaceutical Outsourcing For 2011
By Eric S. Langer, BioPlan Associates
Published June 6, 2011
New study defines trends, growth Read More »
2011 Annual Outsourcing Survey
Published May 15, 2011
Welcome to our 7th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents, by company type & job function: Read More »
2011 Annual Outsourcing Survey
By Gil Y. Roth
Published May 3, 2011
Welcome to our 7th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Read More »
By S. Harachand
Published April 29, 2011
Is a bet on cheaper bio-drugs safe? Read More »
Late-Phase Clinical Technology
By Kate Trainor
Published April 29, 2011
Leveraging new technologies to meet the challenges of post-marketing clinical research Read More »
The Laboratory Data Revolution
By Mike Weaver
Published April 29, 2011
Data Management at the Core Read More »
CROs and the TMF Reference Model
By Maryanne Quinn and Ivan P. Walrath
Published April 29, 2011
Streamlining clinical studies through improved document quality Read More »
CRO Industry Update
By Kristin Brooks
Published April 29, 2011
Leveraging Expertise for Innovation Read More »
Published March 28, 2011
Peter S. Linsley, Ph.D., has been appointed chief scientific officer of AVI BioPharma, Inc., effective May 1, 2011. Read More »
Published March 17, 2011
Ann M. Daus, Ph.D. has been named vice president of Quality at Laureate Biopharmaceutical Services. Read More »
By Steve Snyder
Published March 7, 2011
Timely tips for sponsors Read More »
By Gil Roth
Published March 7, 2011
Plus: this month's reading list Read More »
By Gil Roth
Published March 7, 2011
How are contract service providers positioned for this new market? Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On